Quest Diagnostics Incorporated (0KSX.L)
USD 152.97
(-2.05%)
USD 152.97
(-2.05%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.41 Billion USD | -1.28% |
| 2022 | 4.46 Billion USD | -0.82% |
| 2021 | 4.5 Billion USD | -0.18% |
| 2020 | 4.51 Billion USD | 3.04% |
| 2019 | 4.37 Billion USD | 27.7% |
| 2018 | 3.42 Billion USD | -8.51% |
| 2017 | 3.74 Billion USD | 0.54% |
| 2016 | 3.72 Billion USD | 6.76% |
| 2015 | 3.49 Billion USD | 7.64% |
| 2014 | 3.24 Billion USD | 3.97% |
| 2013 | 3.12 Billion USD | -6.98% |
| 2012 | 3.35 Billion USD | -0.48% |
| 2011 | 3.37 Billion USD | 27.61% |
| 2010 | 2.64 Billion USD | -10.07% |
| 2009 | 2.93 Billion USD | -4.59% |
| 2008 | 3.07 Billion USD | -8.86% |
| 2007 | 3.37 Billion USD | 172.55% |
| 2006 | 1.23 Billion USD | -1.3% |
| 2005 | 1.25 Billion USD | 73.39% |
| 2004 | 724.02 Million USD | -29.62% |
| 2003 | 1.02 Billion USD | 29.15% |
| 2002 | 796.5 Million USD | -2.9% |
| 2001 | 820.33 Million USD | 7.84% |
| 2000 | 760.7 Million USD | -35.06% |
| 1999 | 1.17 Billion USD | 183.36% |
| 1998 | 413.4 Million USD | -14.27% |
| 1997 | 482.2 Million USD | -6.37% |
| 1996 | 515 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 3.81 Billion USD | 0.32% |
| 2024 Q1 | 3.8 Billion USD | -13.74% |
| 2024 Q3 | 5.64 Billion USD | 48.01% |
| 2023 Q3 | 4.45 Billion USD | 3.87% |
| 2023 Q2 | 4.28 Billion USD | -4.03% |
| 2023 FY | 4.41 Billion USD | -1.28% |
| 2023 Q4 | 4.41 Billion USD | -0.92% |
| 2023 Q1 | 4.46 Billion USD | -0.04% |
| 2022 FY | 4.46 Billion USD | -0.82% |
| 2022 Q3 | 4.48 Billion USD | 0.11% |
| 2022 Q4 | 4.46 Billion USD | -0.4% |
| 2022 Q1 | 4.5 Billion USD | 0.07% |
| 2022 Q2 | 4.48 Billion USD | -0.6% |
| 2021 Q4 | 4.5 Billion USD | 0.07% |
| 2021 Q3 | 4.5 Billion USD | 0.02% |
| 2021 FY | 4.5 Billion USD | -0.18% |
| 2021 Q1 | 4.51 Billion USD | 0.02% |
| 2021 Q2 | 4.5 Billion USD | -0.29% |
| 2020 Q2 | 4.43 Billion USD | -0.14% |
| 2020 Q3 | 4.44 Billion USD | 0.23% |
| 2020 FY | 4.51 Billion USD | 3.04% |
| 2020 Q1 | 4.44 Billion USD | 1.44% |
| 2020 Q4 | 4.51 Billion USD | 1.48% |
| 2019 Q4 | 4.37 Billion USD | 21.88% |
| 2019 FY | 4.37 Billion USD | 27.7% |
| 2019 Q1 | 3.52 Billion USD | 2.77% |
| 2019 Q2 | 3.58 Billion USD | 1.65% |
| 2019 Q3 | 3.59 Billion USD | 0.31% |
| 2018 Q3 | 3.39 Billion USD | -0.41% |
| 2018 FY | 3.42 Billion USD | -8.51% |
| 2018 Q4 | 3.42 Billion USD | 1.03% |
| 2018 Q2 | 3.4 Billion USD | -8.34% |
| 2018 Q1 | 3.71 Billion USD | -0.8% |
| 2017 FY | 3.74 Billion USD | 0.54% |
| 2017 Q2 | 3.73 Billion USD | 0.19% |
| 2017 Q1 | 3.72 Billion USD | -0.08% |
| 2017 Q4 | 3.74 Billion USD | -0.29% |
| 2017 Q3 | 3.75 Billion USD | 0.72% |
| 2016 FY | 3.72 Billion USD | 6.76% |
| 2016 Q1 | 3.74 Billion USD | 7.1% |
| 2016 Q2 | 3.83 Billion USD | 2.54% |
| 2016 Q3 | 3.81 Billion USD | -0.52% |
| 2016 Q4 | 3.72 Billion USD | -2.28% |
| 2015 Q1 | 3.68 Billion USD | 13.69% |
| 2015 Q3 | 3.57 Billion USD | 0.08% |
| 2015 Q4 | 3.49 Billion USD | -2.21% |
| 2015 FY | 3.49 Billion USD | 7.64% |
| 2015 Q2 | 3.56 Billion USD | -3.25% |
| 2014 Q3 | 3.73 Billion USD | -0.16% |
| 2014 FY | 3.24 Billion USD | 3.97% |
| 2014 Q1 | 3.72 Billion USD | 19.36% |
| 2014 Q2 | 3.73 Billion USD | 0.38% |
| 2014 Q4 | 3.24 Billion USD | -13.08% |
| 2013 Q2 | 3.12 Billion USD | -0.8% |
| 2013 Q4 | 3.12 Billion USD | -0.07% |
| 2013 Q3 | 3.12 Billion USD | 0.02% |
| 2013 Q1 | 3.14 Billion USD | -6.18% |
| 2013 FY | 3.12 Billion USD | -6.98% |
| 2012 FY | 3.35 Billion USD | -0.48% |
| 2012 Q1 | 3.36 Billion USD | -0.15% |
| 2012 Q2 | 3.37 Billion USD | 0.38% |
| 2012 Q3 | 3.37 Billion USD | -0.07% |
| 2012 Q4 | 3.35 Billion USD | -0.64% |
| 2011 Q3 | 3.36 Billion USD | 1.05% |
| 2011 Q1 | 3.59 Billion USD | 36.1% |
| 2011 FY | 3.37 Billion USD | 27.61% |
| 2011 Q4 | 3.37 Billion USD | 0.08% |
| 2011 Q2 | 3.33 Billion USD | -7.28% |
| 2010 Q1 | 2.94 Billion USD | 0.27% |
| 2010 FY | 2.64 Billion USD | -10.07% |
| 2010 Q3 | 2.83 Billion USD | -4.64% |
| 2010 Q4 | 2.64 Billion USD | -6.87% |
| 2010 Q2 | 2.97 Billion USD | 0.98% |
| 2009 FY | 2.93 Billion USD | -4.59% |
| 2009 Q1 | 3.07 Billion USD | -0.03% |
| 2009 Q2 | 2.87 Billion USD | -6.48% |
| 2009 Q3 | 2.87 Billion USD | -0.0% |
| 2009 Q4 | 2.93 Billion USD | 2.05% |
| 2008 Q1 | 3.37 Billion USD | 0.04% |
| 2008 FY | 3.07 Billion USD | -8.86% |
| 2008 Q4 | 3.07 Billion USD | -0.01% |
| 2008 Q2 | 3.2 Billion USD | -5.01% |
| 2008 Q3 | 3.07 Billion USD | -4.08% |
| 2007 FY | 3.37 Billion USD | 172.55% |
| 2007 Q1 | 1.23 Billion USD | -0.07% |
| 2007 Q3 | 3.47 Billion USD | -2.07% |
| 2007 Q4 | 3.37 Billion USD | -2.72% |
| 2007 Q2 | 3.54 Billion USD | 186.29% |
| 2006 Q2 | 1.24 Billion USD | 0.01% |
| 2006 Q3 | 1.23 Billion USD | -0.13% |
| 2006 Q4 | 1.23 Billion USD | 0.01% |
| 2006 Q1 | 1.24 Billion USD | -1.19% |
| 2006 FY | 1.23 Billion USD | -1.3% |
| 2005 Q3 | 349.39 Million USD | -44.02% |
| 2005 Q4 | 1.25 Billion USD | 259.3% |
| 2005 Q2 | 624.15 Million USD | 0.01% |
| 2005 Q1 | 624.08 Million USD | -13.8% |
| 2005 FY | 1.25 Billion USD | 73.39% |
| 2004 FY | 724.02 Million USD | -29.62% |
| 2004 Q4 | 724.02 Million USD | -25.5% |
| 2004 Q3 | 971.81 Million USD | 0.01% |
| 2004 Q2 | 971.71 Million USD | -8.13% |
| 2004 Q1 | 1.05 Billion USD | 2.82% |
| 2003 FY | 1.02 Billion USD | 29.15% |
| 2003 Q4 | 1.02 Billion USD | -3.42% |
| 2003 Q3 | 1.06 Billion USD | -0.0% |
| 2003 Q2 | 1.06 Billion USD | -6.92% |
| 2003 Q1 | 1.14 Billion USD | 43.67% |
| 2002 Q4 | 796.5 Million USD | -0.03% |
| 2002 FY | 796.5 Million USD | -2.9% |
| 2002 Q3 | 796.77 Million USD | -2.93% |
| 2002 Q2 | 820.81 Million USD | 0.08% |
| 2002 Q1 | 820.19 Million USD | -0.02% |
| 2001 Q3 | 677.91 Million USD | -6.71% |
| 2001 FY | 820.33 Million USD | 7.84% |
| 2001 Q4 | 820.33 Million USD | 21.01% |
| 2001 Q1 | 758.48 Million USD | -0.29% |
| 2001 Q2 | 726.67 Million USD | -4.19% |
| 2000 Q1 | 1.15 Billion USD | -1.15% |
| 2000 Q2 | 1.14 Billion USD | -1.17% |
| 2000 Q4 | 760.7 Million USD | -16.04% |
| 2000 FY | 760.7 Million USD | -35.06% |
| 2000 Q3 | 906.06 Million USD | -20.83% |
| 1999 Q4 | 1.17 Billion USD | -4.8% |
| 1999 FY | 1.17 Billion USD | 183.36% |
| 1999 Q1 | 360.2 Million USD | -12.87% |
| 1999 Q2 | 338.4 Million USD | -6.05% |
| 1999 Q3 | 1.23 Billion USD | 263.62% |
| 1998 FY | 413.4 Million USD | -14.27% |
| 1998 Q4 | 413.4 Million USD | -2.38% |
| 1998 Q1 | 469.4 Million USD | -2.65% |
| 1998 Q3 | 423.5 Million USD | -5.11% |
| 1998 Q2 | 446.3 Million USD | -4.92% |
| 1997 Q4 | 482.2 Million USD | -1.79% |
| 1997 Q2 | 499.2 Million USD | -1.52% |
| 1997 Q1 | 506.9 Million USD | -1.57% |
| 1997 FY | 482.2 Million USD | -6.37% |
| 1997 Q3 | 491 Million USD | -1.64% |
| 1996 Q4 | 515 Million USD | -57.79% |
| 1996 Q3 | 1.22 Billion USD | 0.0% |
| 1996 FY | 515 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -215126.94% |
| Accuray Incorporated | 164.4 Million USD | -2582.482% |
| Align Technology, Inc. | 96.96 Million USD | -4447.892% |
| Elevance Health Inc. | 23.24 Billion USD | 81.029% |
| AxoGen, Inc. | 46.6 Million USD | -9362.91% |
| Boston Scientific Corporation | 8.56 Billion USD | 48.517% |
| CVS Health Corporation | 74.67 Billion USD | 94.094% |
| Cardinal Health, Inc. | 4.58 Billion USD | 3.775% |
| Centene Corporation | 17.69 Billion USD | 75.083% |
| DaVita Inc. | 8.05 Billion USD | 45.226% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 87.96% |
| Hologic, Inc. | 2.49 Billion USD | -76.605% |
| Humana Inc. | 10.21 Billion USD | 56.82% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -607.998% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -8.763% |
| Masimo Corporation | 871.7 Million USD | -405.908% |
| McKesson Corporation | 5.45 Billion USD | 19.097% |
| Patterson Companies, Inc. | 328.91 Million USD | -1240.788% |
| ResMed Inc. | 697.31 Million USD | -532.428% |
| Henry Schein, Inc. | 1.93 Billion USD | -128.143% |
| Teladoc Health, Inc. | 1.58 Billion USD | -178.845% |
| Universal Health Services, Inc. | 4.71 Billion USD | 6.491% |
| Veeva Systems Inc. | 46.44 Million USD | -9395.92% |
| Baxter International Inc. | 11.06 Billion USD | 60.141% |
| Becton, Dickinson and Company | 14.73 Billion USD | 70.077% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 5471.498% |
| Danaher Corporation | 17.66 Billion USD | 75.03% |
| Stryker Corporation | 10.9 Billion USD | 59.545% |
| Medtronic plc | 23.87 Billion USD | 81.53% |